ProShares Ultra Bloomberg Natural Gas

United States Natural Gas

MicroSectors Gold Miners 3X Leveraged ETN

Altimmune Inc. Common Stock

Direxion Daily Gold Miners Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X ETF

ProShares Ultra Silver

Global X Silver Miners ETF

VanEck Vectors Junior Gold Miners ETF

Direxion Daily FTSE China Bull 3X ETF

ProShares UltraShort Bloomberg Natrl Gas

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

Direxion Daily Gold Miners Bear 3X ETF

Direxion Daily S&P Biotech Bear 3X ETF

ProShares UltraShort Silver

Bank Of Montreal

GraniteShares 2x Long AMZN Daily ETF

GraniteShares 1.5x Long NVDA Daily ETF

Direxion Daily 20+ Yr Trsy Bull 3X ETF

GraniteShares 1.5x Long Coinbase Daily ETF

BloomZ Inc. Ordinary Shares

Edible Garden AG Incorporated Common Stock

Siyata Mobile Inc. Common Shares

TNL Mediagene Ordinary Shares

Neuraxis Inc. Common Stock

Eyenovia Inc. Common Stock

D-Wave Quantum Inc. Common Shares

Click Holdings Limited Ordinary Share

Warby Parker Inc. Class A Common Stock

Mind Medicine (MindMed) Inc. Common Shares

Protagenic Therapeutics Inc. Common Stock

NWTN Inc. Class B Ordinary Shares

Brainstorm Cell Therapeutics Inc. Common Stock

Treasure Global Inc. Common Stock

Classover Holdings Inc. Class B Common Stock

ASP Isotopes Inc. Common Stock

Eagle Materials Inc Common Stock

SCWorx Corp. Common Stock

Luminar Technologies Inc.  Class A Common Stock

Canaan Inc. American Depositary Shares

Click here to get full coverage on FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025 - PR Newswire

FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025  PR Newswire

FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025 - PR Newswire

Click here to get full coverage on Precigen, Inc.'s (NASDAQ:PGEN) Profit Outlook - Yahoo Finance

Precigen, Inc.'s (NASDAQ:PGEN) Profit Outlook  Yahoo Finance

Precigen, Inc.'s (NASDAQ:PGEN) Profit Outlook - Yahoo Finance

Click here to get full coverage on Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates - Nasdaq

Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates  Nasdaq

Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates - Nasdaq

Click here to get full coverage on Precigen's Breakthrough RRP Treatment Achieves 51% Complete Response, FDA Decision by August - Stock Titan

Precigen's Breakthrough RRP Treatment Achieves 51% Complete Response, FDA Decision by August  Stock Titan

Precigen's Breakthrough RRP Treatment Achieves 51% Complete Response, FDA Decision by August - Stock Titan

Click here to get full coverage on Why Precigen, Inc. (PGEN) is Skyrocketing So Far in 2025 - Yahoo Finance

Why Precigen, Inc. (PGEN) is Skyrocketing So Far in 2025  Yahoo Finance

Why Precigen, Inc. (PGEN) is Skyrocketing So Far in 2025 - Yahoo Finance

Click here to get full coverage on Breakthrough RRP Treatment PRGN-2012 Nears FDA Decision with 51% Complete Response Rate - Stock Titan

Breakthrough RRP Treatment PRGN-2012 Nears FDA Decision with 51% Complete Response Rate  Stock Titan

Breakthrough RRP Treatment PRGN-2012 Nears FDA Decision with 51% Complete Response Rate - Stock Titan

Click here to get full coverage on $PGEN Earnings Preview: Recent $PGEN Insider Trading, Hedge Fund Activity, and More - Nasdaq

$PGEN Earnings Preview: Recent $PGEN Insider Trading, Hedge Fund Activity, and More  Nasdaq

$PGEN Earnings Preview: Recent $PGEN Insider Trading, Hedge Fund Activity, and More - Nasdaq

Click here to get full coverage on Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis - PR Newswire

Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis  PR Newswire

Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis - PR Newswire

Click here to get full coverage on PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally? - Yahoo Finance

PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally?  Yahoo Finance

PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally? - Yahoo Finance

Click here to get full coverage on Precigen Gene Therapy Pioneer Reveals 2024 Performance: Key Financial Results Coming March 19 - Stock Titan

Precigen Gene Therapy Pioneer Reveals 2024 Performance: Key Financial Results Coming March 19  Stock Titan

Precigen Gene Therapy Pioneer Reveals 2024 Performance: Key Financial Results Coming March 19 - Stock Titan

Click here to get full coverage on Precigen Announces Pricing of $30.0 Million Public Offering of Common Stock - PR Newswire

Precigen Announces Pricing of $30.0 Million Public Offering of Common Stock  PR Newswire

Precigen Announces Pricing of $30.0 Million Public Offering of Common Stock - PR Newswire

Click here to get full coverage on Precigen (NASDAQ:PGEN shareholders incur further losses as stock declines 13% this week, taking five-year losses to 86% - Yahoo Finance

Precigen (NASDAQ:PGEN shareholders incur further losses as stock declines 13% this week, taking five-year losses to 86%  Yahoo Finance

Precigen (NASDAQ:PGEN shareholders incur further losses as stock declines 13% this week, taking five-year losses to 86% - Yahoo Finance

Click here to get full coverage on Major Rare Disease Summit: Precigen Tackles RRP Crisis Affecting 125,000 Patients - Stock Titan

Major Rare Disease Summit: Precigen Tackles RRP Crisis Affecting 125,000 Patients  Stock Titan

Major Rare Disease Summit: Precigen Tackles RRP Crisis Affecting 125,000 Patients - Stock Titan

Click here to get full coverage on Precigen Reports Third Quarter 2024 Financial Results and Business Updates - PR Newswire

Precigen Reports Third Quarter 2024 Financial Results and Business Updates  PR Newswire

Precigen Reports Third Quarter 2024 Financial Results and Business Updates - PR Newswire

Click here to get full coverage on Is Precigen (PGEN) The Hot Biotech Stock Under $5? - Yahoo Finance

Is Precigen (PGEN) The Hot Biotech Stock Under $5?  Yahoo Finance

Is Precigen (PGEN) The Hot Biotech Stock Under $5? - Yahoo Finance

Click here to get full coverage on Precigen to Present Plans for Realizing Commercial Vision for PRGN-2012 at the 43rd Annual J.P. Morgan Healthcare Conference - PR Newswire

Precigen to Present Plans for Realizing Commercial Vision for PRGN-2012 at the 43rd Annual J.P. Morgan Healthcare Conference  PR Newswire

Precigen to Present Plans for Realizing Commercial Vision for PRGN-2012 at the 43rd Annual J.P. Morgan Healthcare Conference - PR Newswire

Click here to get full coverage on Precigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy Launch - PR Newswire

Precigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy Launch  PR Newswire

Precigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy Launch - PR Newswire

Click here to get full coverage on Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates - PR Newswire

Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates  PR Newswire

Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates - PR Newswire

Click here to get full coverage on Precigen Announces Proposed $30 Million Public Offering of Common Stock - PR Newswire

Precigen Announces Proposed $30 Million Public Offering of Common Stock  PR Newswire

Precigen Announces Proposed $30 Million Public Offering of Common Stock - PR Newswire

Click here to get full coverage on Precigen CEO to Present at J.P. Morgan Healthcare Conference 2025 - Stock Titan

Precigen CEO to Present at J.P. Morgan Healthcare Conference 2025  Stock Titan

Precigen CEO to Present at J.P. Morgan Healthcare Conference 2025 - Stock Titan

Click here to get full coverage on Precigen Inc (PGEN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Seizing ... - Yahoo Finance

Precigen Inc (PGEN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Seizing ...  Yahoo Finance

Precigen Inc (PGEN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Seizing ... - Yahoo Finance

Click here to get full coverage on Precigen (PGEN) Secures $79M Strategic Financing, Extends Runway to 2026 for PRGN-2012 Launch - Stock Titan

Precigen (PGEN) Secures $79M Strategic Financing, Extends Runway to 2026 for PRGN-2012 Launch  Stock Titan

Precigen (PGEN) Secures $79M Strategic Financing, Extends Runway to 2026 for PRGN-2012 Launch - Stock Titan

Click here to get full coverage on After-Hours Earnings Report for March 19, 2025 : FIVE, YY, WS, CAPR, NOA, PGEN, GROY, SCPH, AEVA, LFT, SERA, PRSO - Nasdaq

After-Hours Earnings Report for March 19, 2025 : FIVE, YY, WS, CAPR, NOA, PGEN, GROY, SCPH, AEVA, LFT, SERA, PRSO  Nasdaq

After-Hours Earnings Report for March 19, 2025 : FIVE, YY, WS, CAPR, NOA, PGEN, GROY, SCPH, AEVA, LFT, SERA, PRSO - Nasdaq

Click here to get full coverage on Precigen: Successful Proof Of Platform, But Cash Worries Remain (NASDAQ:PGEN) - Seeking Alpha

Precigen: Successful Proof Of Platform, But Cash Worries Remain (NASDAQ:PGEN)  Seeking Alpha

Precigen: Successful Proof Of Platform, But Cash Worries Remain (NASDAQ:PGEN) - Seeking Alpha

Click here to get full coverage on Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch - PR Newswire

Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch  PR Newswire

Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch - PR Newswire

Click here to get full coverage on TVA Documents Reveal New Details About How America’s Major Utilities Fight Clean Air Regulations - Energy and Policy Institute -

TVA Documents Reveal New Details About How America’s Major Utilities Fight Clean Air Regulations  Energy and Policy Institute -

TVA Documents Reveal New Details About How America’s Major Utilities Fight Clean Air Regulations - Energy and Policy Institute -

Click here to get full coverage on Precigen: UltraCAR-T Development Brings Another Side Of Pipeline Advancement (PGEN) - Seeking Alpha

Precigen: UltraCAR-T Development Brings Another Side Of Pipeline Advancement (PGEN)  Seeking Alpha

Precigen: UltraCAR-T Development Brings Another Side Of Pipeline Advancement (PGEN) - Seeking Alpha

Click here to get full coverage on Editorial Note: MiR172- APETALA2-like genes integrate vernalization and plant age to control flowering time in wheat - PLOS

Editorial Note: MiR172- APETALA2-like genes integrate vernalization and plant age to control flowering time in wheat  PLOS

Editorial Note: MiR172- APETALA2-like genes integrate vernalization and plant age to control flowering time in wheat - PLOS

Click here to get full coverage on Should You Invest in Precigen (PGEN)? - MSN

Should You Invest in Precigen (PGEN)?  MSN

Should You Invest in Precigen (PGEN)? - MSN

Click here to get full coverage on Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting - PR Newswire

Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting  PR Newswire

Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting - PR Newswire

Click here to get full coverage on Precigen Completes Series Of Transactions To Solidify Healthcare Focus - PR Newswire

Precigen Completes Series Of Transactions To Solidify Healthcare Focus  PR Newswire

Precigen Completes Series Of Transactions To Solidify Healthcare Focus - PR Newswire

Click here to get full coverage on PGEN Stock Price and Chart — NASDAQ:PGEN - TradingView

PGEN Stock Price and Chart — NASDAQ:PGEN  TradingView

PGEN Stock Price and Chart — NASDAQ:PGEN - TradingView

Click here to get full coverage on The social genome: Current findings and implications for the study of human genetics - PLOS

The social genome: Current findings and implications for the study of human genetics  PLOS

The social genome: Current findings and implications for the study of human genetics - PLOS

Click here to get full coverage on Evolution as a guide for experimental cell biology - PLOS

Evolution as a guide for experimental cell biology  PLOS

Evolution as a guide for experimental cell biology - PLOS

Click here to get full coverage on The gene drive bubble: New realities - PLOS

The gene drive bubble: New realities  PLOS

The gene drive bubble: New realities - PLOS

Click here to get full coverage on Correction: Regulation of ATG4B Stability by RNF5 Limits Basal Levels of Autophagy and Influences Susceptibility to Bacterial Infection - PLOS

Correction: Regulation of ATG4B Stability by RNF5 Limits Basal Levels of Autophagy and Influences Susceptibility to Bacterial Infection  PLOS

Correction: Regulation of ATG4B Stability by RNF5 Limits Basal Levels of Autophagy and Influences Susceptibility to Bacterial Infection - PLOS

Click here to get full coverage on Expression of Concern: NKILA represses nasopharyngeal carcinoma carcinogenesis and metastasis by NF-κB pathway inhibition - PLOS

Expression of Concern: NKILA represses nasopharyngeal carcinoma carcinogenesis and metastasis by NF-κB pathway inhibition  PLOS

Expression of Concern: NKILA represses nasopharyngeal carcinoma carcinogenesis and metastasis by NF-κB pathway inhibition - PLOS

Click here to get full coverage on Correction: Allatostatin A Signalling in Drosophila Regulates Feeding and Sleep and Is Modulated by PDF - PLOS

Correction: Allatostatin A Signalling in Drosophila Regulates Feeding and Sleep and Is Modulated by PDF  PLOS

Correction: Allatostatin A Signalling in Drosophila Regulates Feeding and Sleep and Is Modulated by PDF - PLOS

Click here to get full coverage on PRRG4 function reveals that Robo trafficking is evolutionarily conserved - PLOS

PRRG4 function reveals that Robo trafficking is evolutionarily conserved  PLOS

PRRG4 function reveals that Robo trafficking is evolutionarily conserved - PLOS

Click here to get full coverage on ABCs of Insect Resistance to Bt - PLOS

ABCs of Insect Resistance to Bt - PLOS

Click here to get full coverage on Correction: Functional significance of rare neuroligin 1 variants found in autism - PLOS

Correction: Functional significance of rare neuroligin 1 variants found in autism  PLOS

Correction: Functional significance of rare neuroligin 1 variants found in autism - PLOS

Click here to get full coverage on Morphological Mutations: Lessons from the Cockscomb - PLOS

Morphological Mutations: Lessons from the Cockscomb  PLOS

Morphological Mutations: Lessons from the Cockscomb - PLOS

Click here to get full coverage on Genes influence facial attractiveness through intricate biological relationships - PLOS

Genes influence facial attractiveness through intricate biological relationships  PLOS

Genes influence facial attractiveness through intricate biological relationships - PLOS

Click here to get full coverage on The Silkworm Coming of Age—Early - PLOS

The Silkworm Coming of Age—Early  PLOS

The Silkworm Coming of Age—Early - PLOS

Click here to get full coverage on Combating the Sigatoka Disease Complex on Banana - PLOS

Combating the Sigatoka Disease Complex on Banana  PLOS

Combating the Sigatoka Disease Complex on Banana - PLOS

Click here to get full coverage on Shuffling effector genes through mini-chromosomes - PLOS

Shuffling effector genes through mini-chromosomes  PLOS

Shuffling effector genes through mini-chromosomes - PLOS

Click here to get full coverage on Predicting longevity responses to dietary restriction: A stepping stone toward precision geroscience - PLOS

Predicting longevity responses to dietary restriction: A stepping stone toward precision geroscience  PLOS

Predicting longevity responses to dietary restriction: A stepping stone toward precision geroscience - PLOS

Click here to get full coverage on C. elegans germline cell death, live! - PLOS

C. elegans germline cell death, live!  PLOS

C. elegans germline cell death, live! - PLOS

Click here to get full coverage on Correction: The Roles of Arabidopsis CDF2 in Transcriptional and Posttranscriptional Regulation of Primary MicroRNAs - PLOS

Correction: The Roles of Arabidopsis CDF2 in Transcriptional and Posttranscriptional Regulation of Primary MicroRNAs  PLOS

Correction: The Roles of Arabidopsis CDF2 in Transcriptional and Posttranscriptional Regulation of Primary MicroRNAs - PLOS

Click here to get full coverage on Breaking the Y - PLOS

Breaking the Y - PLOS

Click here to get full coverage on Endless microbes most beautiful and most wonderful - PLOS

Endless microbes most beautiful and most wonderful  PLOS

Endless microbes most beautiful and most wonderful - PLOS

Click here to get full coverage on Correction: The Role of the Mammalian DNA End-processing Enzyme Polynucleotide Kinase 3’-Phosphatase in Spinocerebellar Ataxia Type 3 Pathogenesis - PLOS

Correction: The Role of the Mammalian DNA End-processing Enzyme Polynucleotide Kinase 3’-Phosphatase in Spinocerebellar Ataxia Type 3 Pathogenesis  PLOS

Correction: The Role of the Mammalian DNA End-processing Enzyme Polynucleotide Kinase 3’-Phosphatase in Spinocerebellar Ataxia Type 3 Pathogenesis - PLOS

Click here to get full coverage on Keep on Laying Eggs Mama, RNAi My Reproductive Aging Blues Away - PLOS

Keep on Laying Eggs Mama, RNAi My Reproductive Aging Blues Away  PLOS

Keep on Laying Eggs Mama, RNAi My Reproductive Aging Blues Away - PLOS

Click here to get full coverage on Gene Regulation in Developing Chloroplasts Disentangled - PLOS

Gene Regulation in Developing Chloroplasts Disentangled  PLOS

Gene Regulation in Developing Chloroplasts Disentangled - PLOS

Click here to get full coverage on The anatomy of a nucleus: As revealed by chromosome painting - PLOS

The anatomy of a nucleus: As revealed by chromosome painting  PLOS

Precigen Inc (PGEN)

Price Chart

Key Statistics

Technicals

About PGEN

Latest News

FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025 - PR Newswire

Precigen, Inc.'s (NASDAQ:PGEN) Profit Outlook - Yahoo Finance

Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates - Nasdaq

Advanced Charts

Top Gainers

Top Losers